| 2018年美国ASCO年会晚期乳腺癌内分泌治疗进展 |
| |
| 引用本文： | 石磊,陈占红,王晓稼.2018年美国ASCO年会晚期乳腺癌内分泌治疗进展[J].中国肿瘤临床,2018,45(18):919-921. |
| |
| 作者姓名： | 石磊 陈占红 王晓稼 |
| |
| 作者单位： | 浙江省肿瘤医院乳腺肿瘤内科（杭州市310022） |
| |
| 摘 要： | 内分泌治疗是晚期乳腺癌治疗的主要手段之一，近年来内分泌治疗新药物以及内分泌治疗耐药均为临床研究关注的热点。本文将2018年美国ASCO会议晚期乳腺癌内分泌治疗的进展进行概述。
|
| 关 键 词： | 晚期乳腺癌 内分泌治疗 ASCO |
| 收稿时间： | 2018-08-02 |
ASCO 2018: recent advances in endocrine therapy for advanced breast cancer |
| |
| Institution: | Department of Breast Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China |
| |
| Abstract: | Hormone therapy plays a very important role in advanced breast cancer treatment. In recent years, there has been an increased focus on developing novel endocrine treatment strategies involving new drugs for treatment of endocrine-resistant breast cancer. This review summarizes recent advances in hormone therapy for advanced breast cancer in the American Society of Clinical Oncology Annual Meeting 2018. |
| |
| Keywords: | |
|
| 点击此处可从《中国肿瘤临床》浏览原始摘要信息 |
| 点击此处可从《中国肿瘤临床》下载免费的PDF全文 |
